GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] does anyone have the special authorisation criteria in writing — 11 comments in the full submission. View in context.
79
c/glp1canada·submitted 6 days ago by u/ahmed_abubakar

[Question] does anyone have the special authorisation criteria in writing

Questionbranch of 6 comments

does anyone have the special authorisation criteria in writing. Searched first, found three threads that contradict each other, hence the post. Special authorization is a documented exception process with published criteria. Applications that answer those criteria explicitly, point by point, fare better than general…

Read the full submission and all 11 comments →

This branch

6 comments, started 6 days ago
u/matias_salgado9 points·6 days ago

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

replysharereportpermalink
u/oskar_kaufmann4 points·6 days ago

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

replysharereportpermalink
u/emil_barros3 points·5 days ago

Criteria changed at plan renewal and the denial that had been immovable simply did not apply any more.

replysharereportpermalink
u/controversial_only1 point·6 days ago

Was this a denied authorization or a rejected claim?

replysharereportpermalink
u/ahmed_abubakarOP1 point·5 days ago

Confused a rejected claim with a denied authorization for a month and pursued entirely the wrong process.

replysharereportpermalink
u/paper_trail_paulavetting1 point·5 days ago

That is an employer plan process, and the provincial route is different in both form and timeline.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.